Raymond Joseph Tesi is CEO & President at Inmune Bio, Inc. (INMB). They have made 12 open-market trades across 1 company since 2019, most recently 2024-09-12.
CIK 0001767280
8 open-market purchases totalling $694K since 2019, against 4 sales. Across 8 scored buys the stock is down 20.7% at ninety days, and 25.0 points behind the S&P over the same stretch.
8 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| INMB | 1,554,106 | $2.4M |
Shares reported on the most recent Form 4, priced at the 2024-09-16 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 38% | 38% | 13% |
| Avg Move | +0.5% | +1.6% | -20.7% |
| Alpha | +0.7% | -0.3% | -25.0% |
| Scored | 8 | 8 | 8 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| INMB | BUY | 2024-09-12 | 2024-09-16 | $6.38 | $196K | -9.8% | -5.3% | -7.6% |
| INMB | BUY | 2024-04-19 | 2024-04-24 | $8.32 | $150K | +10.1% | -0.6% | -16.8% |
| INMB | BUY | 2022-05-26 | 2022-05-31 | $6.41 | $40K | +6.2% | +24.9% | +19.4% |
| INMB | SELL | 2021-11-03 | 2021-11-04 | $20.00 | $73K | -21.7% | -36.2% | -44.9% |
| INMB | SELL | 2021-10-27 | 2021-10-29 | $20.00 | $130K | -22.7% | -33.4% | -55.9% |
| INMB | SELL | 2021-10-22 | 2021-10-26 | $20.00 | $472K | -25.4% | -30.3% | -53.7% |
| INMB | SELL | 2021-07-07 | 2021-07-09 | $20.07 | $1.2M | -1.4% | -31.8% | -21.6% |
| INMB | BUY | 2019-08-20 | 2019-08-21 | $6.02 | $14K | -0.8% | -4.8% | -25.9% |
| INMB | BUY | 2019-08-09 | 2019-08-12 | $7.03 | $14K | -0.8% | +1.3% | -24.4% |
| INMB | BUY | 2019-06-03 | 2019-06-04 | $6.00 | $60K | -0.1% | -8.3% | -42.7% |
| INMB | BUY | 2019-05-02 | 2019-05-20 | $10.75 | $119K | +11.9% | +13.2% | -37.6% |
| INMB | BUY | 2019-05-02 | 2019-05-09 | $9.00 | $100K | -12.3% | -7.2% | -29.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.